Active Ingredient History
myo-Inositol trispyrophosphate (ITPP) is an inositol phosphate, a pyrophosphate, a drug candidate, and a putative performance-enhancing substance, which exerts its biological effects by increasing tissue oxygenation. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anovulation (Phase 2)
Anxiety (Phase 1/Phase 2)
Anxiety Disorders (Phase 1/Phase 2)
Asthenozoospermia (Phase 2/Phase 3)
Autism Spectrum Disorder (Phase 4)
Autistic Disorder (Phase 4)
Bipolar Disorder (Phase 4)
Bronchopulmonary Dysplasia (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cholangiocarcinoma (Phase 1/Phase 2)
Clomiphene (Phase 4)
Colitis, Ulcerative (Phase 1/Phase 2)
Colonic Neoplasms (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 1/Phase 2)
Crohn Disease (Phase 1/Phase 2)
Cryopreservation (Phase 1/Phase 2)
Depression (Phase 4)
Diabetes, Gestational (Phase 4)
Diabetes Mellitus, Type 1 (Phase 3)
Dietary Supplements (Phase 4)
Fatigue (Phase 4)
Glucose Intolerance (Phase 2)
Hair (Phase 2)
Humans (Phase 1/Phase 2)
Hyperandrogenism (Phase 2)
Hyperglycemia (Phase 3)
Infant, Low Birth Weight (Phase 2)
Infant, Newborn (Phase 2)
Infant, Premature (Phase 2)
Infant, Small for Gestational Age (Phase 2)
Infertility (Phase 4)
Infertility, Female (Phase 3)
Infertility, Male (Phase 4)
Inositol (Phase 4)
Insulin Resistance (Phase 4)
Learning Disabilities (Phase 4)
Liver Neoplasms (Phase 1/Phase 2)
Lung Diseases (Phase 2)
Lung Neoplasms (Phase 1)
Menopause (Phase 2/Phase 3)
Metabolic Diseases (Phase 2)
Metabolic Syndrome (Phase 4)
Mood Disorders (Phase 4)
Neural Tube Defects (Phase 1)
Obesity (Phase 4)
Oligospermia (Phase 2/Phase 3)
Ovarian Diseases (Phase 2/Phase 3)
Ovulation Induction (Phase 4)
Pancreatic Neoplasms (Phase 1/Phase 2)
Pediatric Obesity (Phase 4)
Periodontitis (Phase 2)
Polycystic Ovary Syndrome (Phase 4)
Precancerous Conditions (Phase 1)
Reproductive Medicine (Phase 3)
Retinopathy of Prematurity (Phase 3)
Spermatozoa (Phase 1/Phase 2)
Trichotillomania (Phase 2)
Zinc (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue